Approval · Notice of Compliance 1070 · 2000

PROCYTOX: Notice of Compliance 1070

Issued March 7, 2000

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 1070
Date: March 7, 2000
Company: Asta Medica Ltd.Halle-Künsebeck, Saone Et Loire, Germany
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Therapeutic class: Antineoplastic agent

Products in this notice

Brand	DIN	Status today
PROCYTOX	02241795	Marketed
PROCYTOX	02241796	Marketed
PROCYTOX	02241797	Marketed
PROCYTOX	02241798	Marketed
PROCYTOX	02241799	Marketed
PROCYTOX	02241800	Marketed

Medicinal ingredients

CYCLOPHOSPHAMIDE 25 MG per TAB
CYCLOPHOSPHAMIDE 50 MG per TAB
CYCLOPHOSPHAMIDE 200 MG per VIAL
CYCLOPHOSPHAMIDE 500 MG per VIAL
CYCLOPHOSPHAMIDE 1,000 MG per VIAL
CYCLOPHOSPHAMIDE 2,000 MG per VIAL